Contact Us
Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System
Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System
Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System

Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System

Nano+™

Nothing Beats Free

Features & Benefits of Nano+™ Polymer-free Sirolimus-eluting Coronary Stent System


  • Nanoporous cavities on strut abluminal surface functioning as drug carrier to ensure the firm adhesion.

  • Vacuum drug coating technology ensures complete drug dosage and coating stability.

  • Post-treatment after drug loading helps with sustained drug release.


Polymer-free Stent


  • Soft tapered tip provides smooth transition from guidewire to balloon catheter and excellent crossability.

  • Short shoulder design at both ends of the balloon ensures the accurate dilation to the lesion, and reduces the damage to normal vessel next to the lesion.

  • Patented hydrophilic coating on distal shaft provides outstanding pushability.


    Polymer-free Stent


  • Polymer-free design significantly reduces the inflammatory response after stent implantation to guarantee the long-term safety.

  • Polymer-free design facilitates earlier endothelialization which significantly shorten the DAPT time.

  • The rough strut surface helps with earlier and easier endothelialization to reduce the risk of thrombosis.

Polymer-free Stent


DES Efficacy [1]


Polymer-free_Stent4.png

BMS Safety [2]


Polymer-free_Stent5.png

Clinical Studies

Specifications

Ordering Information

An OCT Study in Europe Shows Nano+™ A Great Combination of DES Efficacy and BMS Safety [3]. 

In a prospective, multicentre, single-arm, open-label study, OCT examinations 

were performed at three months in 45 patients (47 lesions). 23 patients with 24 lesions 

had serial coronary angiography and OCT assessment at three and six months.


OCT Analyses

OCT Analyses


Coverage Status Of The Individual Stents/Patients At Two Time Points (Three And Six Months)

Coverage Status Of The Individual Stents/Patients At Two Time Points (Three And Six Months

Coverage status of the individual stents/patients at two time points (three and six months).


Serial OCT showed almost complete vascular healing at six months, even when coverage was insufficient at three months. This suggests an adequate safety and efficacy profile of the device at that point in time.



Technical Parameters
Stent Material316L Stainless Steel
Strut DesignNanoporous drug carrier on abluminal   surface
Metal to Artery Ratio15%
Recoil< 2%
Shortening< 1%
Crossing Profile0.035″(0.90mm)



Stent   DiameterStent Length (mm)
(mm)1215182124293336
2.5LPRPS2512LPRPS2515LPRPS2518LPRPS2521LPRPS2524LPRPS2529LPRPS2533-
2.75LPRPS2712LPRPS2715LPRPS2718LPRPS2721LPRPS2724LPRPS2729LPRPS2733LPRPS2736
3LPRPS3012LPRPS3015LPRPS3018LPRPS3021LPRPS3024LPRPS3029LPRPS3033LPRPS3036
3.5LPRPS3512LPRPS3515LPRPS3518LPRPS3521LPRPS3524LPRPS3529LPRPS3533LPRPS3536
4LPRPS4012LPRPS4015LPRPS4018LPRPS4021LPRPS4024LPRPS4029LPRPS4033LPRPS4036

Please contact us for detailed information in your country.



Provide Total Solution For
Patients With
Cardiovascular Disease
Email us with any questions or inquiries or use our contact data. We would be happy to answer your questions.